These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
15. Deutetrabenazine: A Review in Chorea Associated with Huntington's Disease. Heo YA; Scott LJ Drugs; 2017 Nov; 77(17):1857-1864. PubMed ID: 29080203 [TBL] [Abstract][Full Text] [Related]
16. Review of deutetrabenazine: a novel treatment for chorea associated with Huntington's disease. Dean M; Sung VW Drug Des Devel Ther; 2018; 12():313-319. PubMed ID: 29497277 [TBL] [Abstract][Full Text] [Related]
17. Tetrabenazine, a monoamine-depleting drug used in the treatment of hyperkinetic movement disorders. Guay DR Am J Geriatr Pharmacother; 2010 Aug; 8(4):331-73. PubMed ID: 20869622 [TBL] [Abstract][Full Text] [Related]
19. Deutetrabenazine in the treatment of Huntington's disease. Richard A; Frank S Neurodegener Dis Manag; 2019 Feb; 9(1):31-37. PubMed ID: 30624137 [TBL] [Abstract][Full Text] [Related]
20. The psychopharmacology of Huntington disease. Petersén Å; Weydt P Handb Clin Neurol; 2019; 165():179-189. PubMed ID: 31727211 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]